TRPC5 and breast carcinoma: Increased abundance of the Transient Receptor Potential Channel 5 (TrpC5) in EVs was observed in adriamycin-resistant human breast cancer cells (MCF-7/ADM) and was correlated with EV formation; additionally, adriamycin was found in EVs.